A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031623 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anita Csorba und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Semmelweis University, Mária Street 39, H-1085 Budapest, Hungary. Hauptthemen laut MEDLINE: Cystinosis. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cystinosis is a low-prevalence lysosomal storage disease. The pathomechanism involves abnormal functioning of the cystinosine lysosomal cystine transporter (CTNS), causing intraliposomal accumulation of the amino acid cysteine disulfide, which crystallizes and deposits in several parts of the body. The most common ophthalmic complication of cystinosis is the deposition of “gold dust” cystine crystals on the cornea, which already occurs in infancy and leads to severe photosensitivity and dry eyes as it gradually progresses with age. In the specific treatment of cystinosis, preparations containing cysteamine (CYA) are used. The availability of commercialized eyedrops for the targeted treatment is scarce, and only Cystadrops® are commercially available with strong limitations. Thus, magistral CYA-containing compounded eyedrops (CYA-CED) could have a key role in patient care; however, a rationally designed comprehensive study on the commercialized and magistral products is still missing. This work aims to build up a comprehensive study about commercialized and magistral CYA eye drops, involving pharmacokinetic and physicochemical characterization (applying mucoadhesivity, rheology test, investigation of drug release, and parallel artificial membrane permeability assays), as well as ex vivo tests, well supported by statistical analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Semmelweis University, Mária Street 39, H-1085 Budapest, Hungary.
- Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös Street 6, H-6720 Szeged, Hungary.
- Department of Physical Chemistry and Materials Science, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111 Budapest, Hungary.
- Molteam Llc., Mélyfúró Street 4, H-1151 Budapest, Hungary.
- University Pharmacy Department of Pharmacy Administration, Semmelweis University, Hőgyes Endre Street 7-9, H-1092 Budapest, Hungary.
- Department of Pharmaceutical Chemistry, Semmelweis University, Hőgyes Endre Street 7-9, H-1092 Budapest, Hungary.
ORCID-Profile: Gábor Katona, Mária Budai-Szűcs, Diána Balogh-Weiser, Erika Maka, Romána Zelkó, György T Balogh
Zitieren
APA
Csorba, A., Katona, G., Budai-Szűcs, M., Balogh-Weiser, D., Molnár, P., Maka, E., Kazsoki, A., Vajna, M., Zelkó, R., Nagy, Z. Z., & Balogh, G. T. (2024). A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031623
Vancouver
Csorba A, Katona G, Budai-Szűcs M, Balogh-Weiser D, Molnár P, Maka E, et al. A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031623
BibTeX
@article{Csorba2024,
author = {Csorba, Anita and Katona, Gábor and Budai-Szűcs, Mária and Balogh-Weiser, Diána and Molnár, Péter and Maka, Erika and Kazsoki, Adrienn and Vajna, Márton and Zelkó, Romána and Nagy, Zoltán Zsolt and Balogh, György T},
title = {A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031623}
}
EUVIMED